KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger, Claudia Schoch, Martin Dugas, Wolfgang Kern, Peter Staib, Christian Wuchter, Helmut Löffler, Cristina Maria Sauerland, Hubert Serve, Thomas Büchner, Torsten Haferlach, Wolfgang Hiddemann, Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood. ,vol. 100, pp. 59- 66 ,(2002) , 10.1182/BLOOD.V100.1.59

Richard M. Stone, Daniel J. DeAngelo, Virginia Klimek, Ilene Galinsky, Eli Estey, Stephen D. Nimer, Wilson Grandin, David Lebwohl, Yanfeng Wang, Pamela Cohen, Edward A. Fox, Donna Neuberg, Jennifer Clark, D. Gary Gilliland, James D. Griffin, Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 Blood. ,vol. 105, pp. 54- 60 ,(2005) , 10.1182/BLOOD-2004-03-0891

Rory S. Care, Peter J. M. Valk, Anne C. Goodeve, Faisel M. Abu-Duhier, Wendy M. C. Geertsma-Kleinekoort, Giu A. Wilson, Mamdooh A. Gari, Ian R. Peake, Bob Löwenberg, John T. Reilly, Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. British Journal of Haematology. ,vol. 121, pp. 775- 777 ,(2003) , 10.1046/J.1365-2141.2003.04362.X

Alan McIntyre, Brenda Summersgill, Beata Grygalewicz, Ad J.M. Gillis, J. Stoop, Ruud J.H.L.M. van Gurp, Nening Dennis, Cyril Fisher, Robert Huddart, Colin Cooper, Jeremy Clark, J. Wolter Oosterhuis, Leendert H.J. Looijenga, Janet Shipley, Amplification and Overexpression of the KIT Gene Is Associated with Progression in the Seminoma Subtype of Testicular Germ Cell Tumors of Adolescents and Adults Cancer Research. ,vol. 65, pp. 8085- 8089 ,(2005) , 10.1158/0008-5472.CAN-05-0471

Krzysztof Mrózek, Kristiina Heinonen, Clara D. Bloomfield, Clinical importance of cytogenetics in acute myeloid leukaemia Best Practice & Research Clinical Haematology. ,vol. 14, pp. 19- 47 ,(2001) , 10.1053/BEHA.2000.0114

Torsten Haferlach, Susanne Schnittger, Thomas Büchner, Wolfgang Kern, Wolfgang Hiddemann, Claudia Schoch, The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups Haematologica. ,vol. 89, pp. 1082- 1090 ,(2004) , 10.3324/%X

Alessandro Beghini, Gianpaolo Nadali, Patrizia Colapietro, Lidia Larizza, Francesca Elice, Enrica Morra, Giovanni Grillo, Andrea Biondi, Giovanni Cazzaniga, Roberto Cairoli, Oskar A. Haas, Carla B. Ripamonti, KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication Haematologica. ,vol. 89, pp. 920- 925 ,(2004) , 10.3324/%X

Petranel T. Ferrao, Leonie K. Ashman, Michelle J. Frost, Timothy P. Hughes, Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Molecular Cancer Therapeutics. ,vol. 1, pp. 1115- 1124 ,(2002)

M Nakao, JWW Janssen, D Erz, T Seriu, CR Bartram, Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease. Leukemia. ,vol. 14, pp. 522- 524 ,(2000) , 10.1038/SJ.LEU.2401695

Mary Ellen Healy, Martin Sattler, Shalini Verma, Jeffrey Lin, Gautam Maulik, Charles D Stiles, James D Griffin, Bruce E Johnson, Ravi Salgia, Wen-Lan Wang, Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene. ,vol. 19, pp. 3521- 3528 ,(2000) , 10.1038/SJ.ONC.1203698